Adverum Biotech
8 followers
‌
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more
Industries
Headquarters
Employees
Links
Org chart
Laurent Fischer
President & CEO
Laurent Fischer
Collapse
Star Seyedkazemi
Chief Development Officer
R. Andrew Ramelmeier
Chief Technology Officer
Romuald Corbau
Chief Scientific Officer
Rabia Gurses Ozden
Chief Medical Officer
Jason L. Mitchell
Chief Commercial Officer
John Rakow
General Counsel
Dena House
SVP, Human Resources, Organizational Development & Learning
Carla Fiankan
SVP, Regulatory Affairs
Heikki Jouttijärvi
SVP & Head, Technical Operations
Bill Tan
SVP & Head, Global Clinical Operations
Adam Turpcu
Vice President, Clinical Development And Access Strategy
Joanna D.
Associate Director, Clinical Development
Similar companies
Kymera Therapeutics
5 followers
Tectonic Therapeutic
4 followers
Arbutus Biopharma
2 followers
Century Therapeutics
1 follower
ReCode Therapeutics
1 follower
Terray Therapeutics
1 follower
Newlight Technologies
1 follower
Lineage Cell Therapeutics
1 follower
Nucleate
3 followers
Truveta
2 followers
Thermo Fisher Scientific
148 followers
Discover companies